Mn Services Vermogensbeheer B.V. Sells 8,300 Shares of Agilent Technologies, Inc. (NYSE:A)

Mn Services Vermogensbeheer B.V. cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 105,975 shares of the medical research company’s stock after selling 8,300 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Agilent Technologies were worth $12,397,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in A. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after buying an additional 270 shares in the last quarter. Savant Capital LLC lifted its stake in shares of Agilent Technologies by 3.5% during the fourth quarter. Savant Capital LLC now owns 3,535 shares of the medical research company’s stock valued at $475,000 after acquiring an additional 119 shares during the period. Avestar Capital LLC boosted its holdings in Agilent Technologies by 38.9% in the fourth quarter. Avestar Capital LLC now owns 1,893 shares of the medical research company’s stock valued at $254,000 after acquiring an additional 530 shares during the last quarter. Allworth Financial LP increased its position in Agilent Technologies by 55.1% in the fourth quarter. Allworth Financial LP now owns 6,647 shares of the medical research company’s stock worth $893,000 after purchasing an additional 2,361 shares during the period. Finally, Sheaff Brock Investment Advisors LLC bought a new stake in Agilent Technologies during the 4th quarter worth about $789,000.

Insider Buying and Selling

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the transaction, the director now owns 35,737 shares in the company, valued at $4,161,931.02. This trade represents a 4.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Wall Street Analyst Weigh In

A has been the subject of several recent research reports. JPMorgan Chase & Co. dropped their target price on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 29th. Barclays dropped their price objective on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday. TD Cowen boosted their target price on Agilent Technologies to $150.00 and gave the stock a “buy” rating in a research report on Thursday, May 29th. Finally, Jefferies Financial Group cut their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research report on Monday, April 21st. Eight investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $140.15.

Agilent Technologies Trading Down 1.6%

Shares of A stock opened at $116.97 on Monday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09. The stock has a 50 day simple moving average of $109.34 and a two-hundred day simple moving average of $125.29. The company has a market cap of $33.23 billion, a P/E ratio of 28.88, a PEG ratio of 3.55 and a beta of 1.23.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.63 billion. During the same quarter in the prior year, the firm earned $1.22 EPS. The business’s revenue was up 6.0% on a year-over-year basis. Research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.85%. Agilent Technologies’s dividend payout ratio (DPR) is presently 24.44%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.